United Therapeutics Corporation
United Therapeutics Corporation (UTHR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · UTHR · as of Jun 8, 2026
Key Statistics
Explore United Therapeutics Corporation Data
uthr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 30 · Buy rate: 56.7%
The UTHR analyst consensus is Buy, based on ratings from 30 Wall Street analysts over the past 3 months. The average 12-month price target is $636.83, representing +15.81% upside from the current price of $549.87.
Competitors & Peers
uthr competitorsUTHR
BIIB
DGX
GMAB
ILMN
INCYStock Performance
Full HistoryAbout United Therapeutics Corporation
United Therapeutics Corporation a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening …
what is united therapeutics corporation · uthr stock overview · united therapeutics corporation company profile · who is united therapeutics corporation ceo · uthr NASDAQ · united therapeutics corporation headquarters · united therapeutics corporation business segments
About Stock Overview & Key Data
United Therapeutics Corporation (UTHR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 17, 1999. As of the latest trading session, UTHR stock price is $549.87, with a market capitalization of $23.3B. The stock has returned +67.44% over the past 12 months and +12.85% year-to-date.
According to 30 Wall Street analysts, the consensus rating for United Therapeutics Corporation stock is Buy, with an average 12-month price target of $636.83. In fiscal year 2025, United Therapeutics Corporation reported revenue of $3.2B and net income of $1.3B. For detailed data — including United Therapeutics Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, United Therapeutics Corporation (UTHR) stock price is $549.87. The stock is traded on NASDAQ under the ticker symbol UTHR. The 52-week range is $272.12 – $609.35.